Efthymios N. Deliargyris
2021
In 2021, Efthymios N. Deliargyris earned a total compensation of $1.2M as Chief Medical Officer at Cytosorbents, a 44% increase compared to previous year.
Compensation breakdown
| Bonus | $101,005 |
|---|---|
| Option Awards | $313,513 |
| Salary | $408,100 |
| Stock Awards | $359,600 |
| Other | $12,500 |
| Total | $1,194,718 |
Deliargyris received $408.1K in salary, accounting for 34% of the total pay in 2021.
Deliargyris also received $101K in bonus, $313.5K in option awards, $359.6K in stock awards and $12.5K in other compensation.
Rankings
In 2021, Efthymios N. Deliargyris' compensation ranked 8,131st out of 12,415 executives tracked by ExecPay. In other words, Deliargyris earned more than 34.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,131 out of 12,415 | 35th |
Division Manufacturing | 3,595 out of 5,508 | 35th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 463 out of 801 | 42nd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 290 out of 522 | 44th |
Industry Surgical and Medical Instruments and Apparatus | 186 out of 327 | 43rd |
Source: SEC filing on April 22, 2022.
Deliargyris' colleagues
We found three more compensation records of executives who worked with Efthymios N. Deliargyris at Cytosorbents in 2021.